Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'21
Mar'20
Net Sales
96.99
103.83
77.48
48.84
28.60
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
96.99
103.83
77.48
48.84
28.60
Raw Material Cost
62.93
77.76
61.15
39.67
21.75
Purchase of Finished goods
1.33
2.62
0.53
0.23
0.16
(Increase) / Decrease In Stocks
4.05
-0.76
-4.41
-0.51
-0.49
Employee Cost
3.17
4.00
4.23
2.82
1.71
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.00
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
Other Expenses
11.86
11.71
8.73
5.18
3.60
Total Expenditure (Excl Depreciation)
83.34
95.32
70.23
47.39
26.74
Operating Profit (PBDIT) excl Other Income
13.65
8.51
7.25
1.45
1.86
Other Income
3.90
0.49
0.35
0.11
0.22
Operating Profit (PBDIT)
17.55
9.00
7.60
1.56
2.08
Interest
2.58
1.70
1.98
1.02
0.33
Exceptional Items
0.00
-0.23
0.58
0.00
0.00
Gross Profit (PBDT)
14.97
7.07
6.20
0.54
1.75
Depreciation
3.84
3.10
2.28
2.59
1.40
Profit Before Tax
11.12
3.96
3.93
-2.06
0.36
Tax
1.84
0.38
1.64
0.31
0.27
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
9.28
3.58
2.29
-2.37
0.09
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
9.28
3.58
2.29
-2.37
0.09
Share in Profit of Associates
-1.25
0.70
0.59
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
8.03
4.28
2.88
-2.37
0.09
Equity Capital
11.05
11.05
8.05
2.30
2.30
Face Value
10.0
10.0
10.0
10.0
10.0
Reserves
42.20
34.21
1.94
0.00
0.00
Earnings per share (EPS)
7.27
3.87
3.58
-10.3
0.39
Diluted Earnings per share
7.26
3.9
3.58
-10.28
0.89
Operating Profit Margin (Excl OI)
14.07%
8.2%
9.36%
2.97%
6.5%
Gross Profit Margin
15.43%
6.81%
8.0%
1.11%
6.12%
PAT Margin
9.57%
3.45%
2.96%
-4.85%
0.31%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -6.59% vs 34.01% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 87.62% vs 48.61% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 60.40% vs 17.38% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 51.76% vs -14.14% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Sotac Pharma. With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
96.99
19.40
77.59
399.95%
Other Operating Income
0.00
0.00
0.00
Total Operating income
96.99
19.40
77.59
399.95%
Raw Material Cost
62.93
5.06
57.87
1,143.68%
Purchase of Finished goods
1.33
0.02
1.31
6,550.00%
(Increase) / Decrease In Stocks
4.05
4.13
-0.08
-1.94%
Employee Cost
3.17
2.47
0.70
28.34%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
11.86
4.31
7.55
175.17%
Total Expenditure (Excl Depreciation)
83.34
15.99
67.35
421.20%
Operating Profit (PBDIT) excl Other Income
13.65
3.41
10.24
300.29%
Other Income
3.90
0.66
3.24
490.91%
Operating Profit (PBDIT)
17.55
4.07
13.48
331.20%
Interest
2.58
1.08
1.50
138.89%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
14.97
2.99
11.98
400.67%
Depreciation
3.84
1.10
2.74
249.09%
Profit Before Tax
11.12
1.88
9.24
491.49%
Tax
1.84
0.04
1.80
4,500.00%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
9.28
1.84
7.44
404.35%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
9.28
1.84
7.44
404.35%
Share in Profit of Associates
-1.25
0.00
-1.25
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
8.03
1.84
6.19
336.41%
Equity Capital
11.05
6.23
4.82
77.37%
Face Value
10.00
10.00
0.00
Reserves
42.20
36.74
5.46
14.86%
Earnings per share (EPS)
7.27
2.95
4.32
146.44%
Diluted Earnings per share
7.26
2.95
4.31
146.10%
Operating Profit Margin (Excl OI)
14.07%
17.58%
0.00
-3.51%
Gross Profit Margin
15.43%
15.41%
0.00
0.02%
PAT Margin
9.57%
9.48%
0.00
0.09%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 96.99 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -6.59% vs 34.01% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 8.03 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 87.62% vs 48.61% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.65 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 60.40% vs 17.38% in Mar 2024
Annual - Interest
Interest 2.58 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 51.76% vs -14.14% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.07%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
